P2EP- Plant Pathways Elucidation Project
The Plant Pathways Elucidation Project, or P2EP, is a groundbreaking multi-million dollar program that engages college students from across North Carolina in a first-of-its-kind education and research endeavor.
For more information about P2EP, e-mail Program Coordinator Ebony Powers Waterman.
To read about the 2016 class of P2EP interns, click here.
At its core, P2EP is a student-driven initiative that fuses plant science with human health. The program is fueled by one of the largest consortium of academic and industry organizations ever assembled at the NC Research Campus. The program teams up university scientists, industry leaders and college students who together explore plant pathways to answer why and how plants, like fruits and vegetables, benefit human health.
Science students from North Carolina colleges and universities gain research experience in a multidisciplinary, collaborative environment – one-of-a-kind scientific research opportunities – which better prepares them for successful career.
- Cabarrus Economic Development Corporation
- Catawba College
- David H. Murdock Research Institute
- Dole Nutrition Research Laboratory
- Duke Energy Foundation
- General Mills
- Holiday Inn Express- Kannapolis
- NC Research Campus
- NC State University Plants for Human Health Institute
- Turner Construction
- UNC General Administration
- University of North Carolina at Charlotte
More information at www.p2ep.org.
2016 Summer Research Symposium:
When: Wednesday, July 27, 2016 | 10:00 a.m. – 4:00 p.m.
Where: Laureate Center, Kannapolis City Hall | 401 Laureate Way, Kannapolis, NC 28081
Keynote Speaker: Rudolphe Barrangou, PhD
Barrangou is a pioneer in the field of CRISPR technology, a tool developed from a bacterial protective mechanism that scientists have modified to serve human purposes. Barrangou earned his PhD in functional engineering from NC State in 2004, and he has been working with CRISPR ever since. CRISPR systems have the potential to treat bacterial infections when current drugs fail due to antibiotic-resistant bacterial species. Barrangou believes the possibilities for CRISPR applications are endless, simply waiting to be discovered.
Missed the symposium? No worries. Several videos of the research presentations are available online.